Emergence of High-Level Gentamicin Resistance in <i>Streptococcus agalactiae</i> Hypervirulent Serotype IV ST1010 (CC452) Strains by Acquisition of a Novel Integrative and Conjugative Element

<i>Streptococcus agalactiae</i> (group B streptococci, GBS) is responsible for severe infections in both neonates and adults. Currently, empiric antimicrobial therapy for sepsis and meningitis is the combined use of penicillin and gentamicin due to the enhanced bactericidal activity. How...

Full description

Saved in:
Bibliographic Details
Main Authors: Roberta Creti (Author), Monica Imperi (Author), Uzma Basit Khan (Author), Alberto Berardi (Author), Simona Recchia (Author), Giovanna Alfarone (Author), Giovanni Gherardi (Author)
Format: Book
Published: MDPI AG, 2024-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_971037e0cf0b4c74b32ba56bd1a00d06
042 |a dc 
100 1 0 |a Roberta Creti  |e author 
700 1 0 |a Monica Imperi  |e author 
700 1 0 |a Uzma Basit Khan  |e author 
700 1 0 |a Alberto Berardi  |e author 
700 1 0 |a Simona Recchia  |e author 
700 1 0 |a Giovanna Alfarone  |e author 
700 1 0 |a Giovanni Gherardi  |e author 
245 0 0 |a Emergence of High-Level Gentamicin Resistance in <i>Streptococcus agalactiae</i> Hypervirulent Serotype IV ST1010 (CC452) Strains by Acquisition of a Novel Integrative and Conjugative Element 
260 |b MDPI AG,   |c 2024-05-01T00:00:00Z. 
500 |a 10.3390/antibiotics13060491 
500 |a 2079-6382 
520 |a <i>Streptococcus agalactiae</i> (group B streptococci, GBS) is responsible for severe infections in both neonates and adults. Currently, empiric antimicrobial therapy for sepsis and meningitis is the combined use of penicillin and gentamicin due to the enhanced bactericidal activity. However, high-level gentamicin resistance (HLGR) abrogates the synergism. The rate of HLGR was investigated within a dataset of 433 GBS strains collected from cases of invasive disease in both adults and neonates as well as from pregnant carriers. GBS isolates (n = 20, 4.6%) presented with HLGR (gentamicin MIC breakpoint >1024 mg/L) that was differently diffused between strains from adults or neonates (5.2% vs. 2.8%). Notably, 70% of HLGR GBS strains (14 isolates) were serotype IV. Serotype IV HLGR-GBS isolates were susceptible to all antibiotics tested, exhibited the alpha-C/HvgA/PI-2b virulence string, and belonged to sequence type 1010 (clonal complex (CC) 452). The mobile element that harbored the HLGR <i>aac</i>(6')-<i>aph</i>(2)" gene is a novel integrative and conjugative element (ICE) about 45 kb long, derived from GBS 515 ICE tRNA<sup><i>Lys</i></sup>. The clonal expansion of this HLGR hypervirulent serotype IV GBS CC452 sublineage may pose a threat to the management of infections caused by this strain type. 
546 |a EN 
690 |a <i>Streptococcus agalactiae</i> 
690 |a GBS 
690 |a high-level gentamicin resistance (HLGR) 
690 |a ST1010 
690 |a serotype IV 
690 |a CC452 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antibiotics, Vol 13, Iss 6, p 491 (2024) 
787 0 |n https://www.mdpi.com/2079-6382/13/6/491 
787 0 |n https://doaj.org/toc/2079-6382 
856 4 1 |u https://doaj.org/article/971037e0cf0b4c74b32ba56bd1a00d06  |z Connect to this object online.